Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Treatment of the Crigler-Najjar syndrome type 1 with hepatocyte transplantation

Article Abstract:

Transplantation of liver cells may be a promising treatment for Crigler-Najjar syndrome type 1. This disease is caused by a defect in the enzyme that metabolizes bilirubin, a chemical produced by the body. Researchers transplanted liver cells taken from a deceased boy into a 10-year-old girl with this disorder. About one month after the transplant, the level of bilirubin in her blood dropped to half its pre-transplant level. She also had enzyme activity and evidence that the bilirubin was being metabolized. Her transplanted cells lasted for more than 11 months.

Author: Dorko, Kenneth, Strom, Stephen C., Kaufman, Stuart S., Fox, Ira J., Chowdhury, Jayanta Roy, Chowdhury, Namita Roy, Goertzen, Timothy C., Warkentin, Phyllis I., Sauter, Bernhard V.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Health aspects, Care and treatment, Liver, Liver transplantation, Hyperbilirubinemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

Article Abstract:

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) may be too toxic to the liver to be used as chemotherapy in humans. Although it can induce apoptosis in cancer cells, it also caused massive death of normal human hepatocytes.

Author: Jo, Minji, Kim, Tae-Hyoung, Seol, Dai-Wu, Esplen, James E., Dorko, Kenneth, Billiar, Timothy R., Strom, Stephen C.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2000
Cell death, Antineoplastic agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Converting hepatocytes to beta-cells -- a new approach for diabetes?

Article Abstract:

Transferring the homeobox gene PDX-1 into liver cells makes the cells produce insulin. Liver cells could be engineered to act like pancreatic beta cells, providing a source of insulin for diabetics.

Author: Kahn, Axel
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2000
Diabetes, Genetic engineering, Insulin, Diabetes research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Liver cells, Hepatocytes, Research, Physiological aspects
Similar abstracts:
  • Abstracts: Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors
  • Abstracts: Effects of theophylline on erythropoietin production in normal subjects in patients with erythrocytosis after renal transplantation
  • Abstracts: Elective cyclosporine withdrawal after renal transplantation: a meta-analysis. Payment for Immunosuppression After Organ Transplantation
  • Abstracts: Effectiveness of sealant treatment over five years in an insured population. A clinical evaluation of air-abrasion treatment of questionable carious lesions: a 12-month report
  • Abstracts: Twins and triplets: The effect of plurality and growth on neonatal outcome compared with singleton infants. Appendicitis in pregnancy: new information that contradicts long-held clinical beliefs
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.